"Any Python developer should be able to bring their business users closer to fresh, reliable data," Matthias Krzykowski, dltHub's co-founder and CEO told VentureBeat in an exclusive interview. "Our ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Microbes such as viruses, bacteria, and protozoa often cause infections in a variety of organisms, with the course and outcome of these infections being shaped by intricate interactions between the ...

CREATE Medicines ("CREATE") broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, ...